超声、增强磁共振及联合应用评估乳腺癌新辅助化疗疗效的价值及ROC分析

ROC analysis on the value of ultrasound and contrast-enhanced magnetic resonance used alone or in combination in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer

探讨常规超声、增强磁共振及两者联合应用在乳腺癌新辅助化疗疗效评估中的临床价值。研究发现常规超声及增强磁共振对乳腺癌的新辅助化疗评估均具有重要的临床价值,准确判断化疗效果,对化疗方案的指导和调整极其重要,联合利用两种方法对新辅助化疗效果的判定可能具有更高的临床价值,从而更加准确的调整治疗方案。

The purpose of this study was to determine the value of ultrasound and contrast-enhanced magnetic resonance imaging(MRI)used alone or in combination in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer.The present study demonstrated the important clinical value of conventional ultrasound and contrast-enhanced MRI in the efficacy evaluation of neoadjuvant chemotherapy for breast cancer,especially in accurate determination of the chemotherapy outcome,guidance and adjustment of chemotherapy regimen.Combined use of the both can be even more helpful in evaluating the efficacy of neoadjuvant chemotherapy,and may add to more precise adjustment of treatment protocol.